Beltrán-Becerra KJ, Ríos-González BE, Gutiérrez-Amavizca BE, Silva-Noriega DA, Figuera LE. [Ophthalmic manifestations in Mexican patients with Fabry disease].
Arch Soc Esp Oftalmol 2012;
87:373-375. [PMID:
23058197 DOI:
10.1016/j.oftal.2011.09.008]
[Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/23/2011] [Accepted: 09/14/2011] [Indexed: 06/01/2023]
Abstract
UNLABELLED
Fabry disease (FD) is a rare X-linked genetic lysosomal storage disease caused by a deficiency of the enzyme α-galactosidase A, that produces accumulation of globotriaosylceramide. There is a multisystemic involvement, including renal, cardiac, eye, and nervous system manifestations.
AIM
To perform a descriptive analysis of the ophthalmological manifestations in Mexican patients with FD.
MATERIAL AND METHODS
We studied 13 patients with clinical and biochemical diagnostic of FD.
RESULTS
Cornea verticillata was found in 57% of men and 33% carriers.
CONCLUSION
Cornea verticillata was the most common ocular manifestation in males and carriers of FD in Mexico.
Collapse